PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-63.52%
Both yoy net incomes decline, with CRK at -74.13%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
30.00%
Some D&A expansion while CRK is negative at -72.63%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
128.44%
Some yoy growth while CRK is negative at -50.98%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-129.41%
Negative yoy SBC while CRK is 20.92%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
4540.00%
Well above CRK's 288.32% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
694.58%
AR growth well above CRK's 118.40%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-862.36%
Negative yoy inventory while CRK is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-232.88%
Both negative yoy AP, with CRK at -153.66%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
4540.00%
Growth well above CRK's 99.52%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
92.42%
Well above CRK's 91.65%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
22.06%
Some CFO growth while CRK is negative at -17.50%. John Neff would note a short-term liquidity lead over the competitor.
-70.39%
Both yoy lines negative, with CRK at -23.87%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
26.38%
Some acquisitions while CRK is negative at -96.82%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-414.29%
We reduce yoy other investing while CRK is 95.06%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-46.02%
Both yoy lines negative, with CRK at -13.07%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-7000.00%
We cut debt repayment yoy while CRK is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-27.13%
We cut yoy buybacks while CRK is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.